Video Experimental Relacionado
Updated: Jul 15, 2026
12:55
High-throughput Functional Screening using a Homemade Dual-glow Luciferase Assay
Published on: June 1, 2014
La duplicación del locus alfa-sinucleína como causa de la enfermedad de Parkinson familiar
Marie-Christine Chartier-Harlin1, Jennifer Kachergus, Christophe Roumier
1Unité INSERM 508, 1 rue du Pr Calmette, BP 245, 59019 Lille Cedex, France.
Lancet (London, England)
|September 29, 2004
Resumen
La duplicación genómica del gen alfa-sinucleína (SNCA) causa la enfermedad de Parkinson que se asemeja a la forma idiopática. El aumento de la dosis del gen SNCA se correlaciona con la progresión de la enfermedad, lo que afecta el inicio y la gravedad.
Área de la Ciencia:
- La neurogenética es la neurogenética.
- Neurología Molecular Neurología Molecular
- Investigación de la Enfermedad de Parkinson.
Sus antecedentes:
- La triplicación genómica del gen alfa-sinucleína (SNCA) está relacionada con el parkinsonismo hereditario de inicio temprano con demencia.
- Investigar la multiplicación del locus SNCA es crucial para comprender la patogénesis de la enfermedad de Parkinson (EP).
Objetivo del estudio:
- Para detectar la multiplicación del locus SNCA en familias con parkinsonismo autosómico dominante.
- Para caracterizar el fenotipo clínico asociado con la duplicación de SNCA.
Principales métodos:
- Se utilizó la PCR semi-cuantitativa para detectar la duplicación de SNCA.
- El análisis fluorescente de hibridación in situ (FISH) confirmó la duplicación en leucocitos periféricos.
Principales resultados:
- Se identificó una familia con parkinsonismo autosómico dominante con duplicación SNCA.
- La presentación clínica de la duplicación de SNCA refleja la enfermedad de Parkinson idiopática, con inicio tardío y progresión lenta sin un importante deterioro cognitivo o demencia.
Conclusiones:
- La dosis del gen SNCA influye directamente en la progresión de la enfermedad de Parkinson.
- La duplicación de SNCA presenta un fenotipo distinto en comparación con la triplicación de SNCA, lo que sugiere efectos dependientes de la dosis del gen en las características de la enfermedad.
Videos de Conceptos Relacionados
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...